Bio-Techne Corporation (TECH)
Biotech firm Bio-Techne beats quarterly estimates on strength in key unit
Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development.
Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock?
TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.
Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
CMB.TECH NV (CMBT) Q3 2025 Earnings Call Transcript
CMB.TECH NV ( CMBT ) Q3 2025 Earnings Call November 26, 2025 8:00 AM EST Company Participants Alexander Saverys - CEO & Member of Management Board Ludovic Saverys - CFO & Member of Management Board Enya Derkinderen - Brand Manager Conference Call Participants Frode Morkedal - Clarksons Platou Securities AS, Research Division Eirik Haavaldsen - Pareto Securities AS, Research Division Kristof Samoy - KBC Securities NV, Research Division Climent Molins - Value Investor's Edge Kristoffer Skeie - Arctic Securities AS, Research Division Axel Styrman - Kepler Cheuvreux, Research Division Quirijn Mulder - ING Groep N.V., Research Division Presentation Alexander Saverys CEO & Member of Management Board Good afternoon and welcome to the Cmb.Tech's Earnings Conference Call for the Third Quarter of 2025.
Bio-Techne Corporation (TECH) Presents at Jefferies London Healthcare Conference 2025 Transcript
Bio-Techne Corporation ( TECH ) Jefferies London Healthcare Conference 2025 November 20, 2025 7:30 AM EST Company Participants James Hippel - Executive VP of Finance & CFO Conference Call Participants Tycho Peterson Tycho Peterson Presentation Tycho Peterson Okay. Great. We're going to kick it off.
Bio-Techne Corporation (TECH) Presents at Stephens Annual Investment Conference 2025 Transcript
Bio-Techne Corporation ( TECH ) Stephens Annual Investment Conference 2025 November 18, 2025 9:00 AM EST Company Participants James Hippel - Executive VP of Finance & CFO William Geist - President of Protein Sciences Segment Conference Call Participants Steven Etoch - Stephens Inc., Research Division Presentation Steven Etoch Stephens Inc., Research Division [Audio Gap] Is intended to be more of a fireside chat, so I'll stop along the way and poll for any questions. So feel free to chime in as needed.
Bio-Techne Corporation (TECH) Presents at Stifel 2025 Healthcare Conference Transcript
Bio-Techne Corporation ( TECH ) Stifel 2025 Healthcare Conference November 11, 2025 9:20 AM EST Company Participants Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance & CFO Conference Call Participants Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Daniel Arias Stifel, Nicolaus & Company, Incorporated, Research Division Okay. We'll go ahead and get started.
Bio-Techne Corporation (TECH) Presents at UBS Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation ( TECH ) UBS Global Healthcare Conference 2025 November 10, 2025 10:15 AM EST Company Participants Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance & CFO Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Presentation Daniel Leonard UBS Investment Bank, Research Division Our next session here is the management team from Bio-Techne. We're lucky to be joined by Kim Kelderman, Jim Hippel and Dave Clair.
Bio-Techne Corporation (TECH) Q1 2026 Earnings Call Transcript
Bio-Techne Corporation ( TECH ) Q1 2026 Earnings Call November 5, 2025 9:00 AM EST Company Participants David Clair - VP of Investor Relations & Corporate Development Kim Kelderman - CEO, President & Director James Hippel - Executive VP of Finance & CFO Conference Call Participants Daniel Leonard - UBS Investment Bank, Research Division Matthew Larew - William Blair & Company L.L.C., Research Division Puneet Souda - Leerink Partners LLC, Research Division Patrick Donnelly - Citigroup Inc., Research Division Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Kyle Boucher - TD Cowen, Research Division Catherine Ramsey - Robert W.
